Sensei Biotherapeutics In...

0.44
0.01 (2.09%)
At close: Mar 04, 2025, 10:11 AM

Sensei Biotherapeutics Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue n/a n/a n/a n/a n/a n/a
Cost of Revenue 571K 1.81M 685K 209K 73K 44K
Gross Profit -571K -1.81M -685K -209K -73K -44K
Operating Income -37.06M -50.19M -37.48M -19.45M -12.44M -12.74M
Interest Income 3.62M 1.78M 800K 1.69K 2.26K n/a
Pretax Income -34.1M -48.59M -36.79M -20.1M -16.74M -13.04M
Net Income -34.1M -48.81M -37.46M -20.63M -19M -13.04M
Selling & General & Admin 18.77M 19.8M 15.82M 7.53M 4.08M 4.51M
Research & Development 18.3M 30.38M 21.66M 11.19M 8.35M 8.23M
Other Expenses n/a 1.6M 688K -649K -1K 28K
Operating Expenses 37.06M 50.19M 37.48M 18.71M 12.44M 12.74M
Interest Expense 144K 219K 670K 1.69M 2.26M 327K
Selling & Marketing Expenses 100K n/a n/a n/a n/a n/a
Cost & Expenses 37.06M 50.19M 37.48M 18.71M 12.44M 12.74M
Income Tax n/a 219K 670K 529K 2.25M 299K
Shares Outstanding (Basic) 27.95M 30.7M 27.71M 30.59M 29.33M 685.16K
Shares Outstanding (Diluted) 27.95M 30.7M 27.71M 30.59M 29.33M 685.16K
EPS (Basic) -1.22 -1.59 -1.35 -0.67 -0.65 -19.03
EPS (Diluted) -1.22 -1.59 -1.35 -0.67 -0.65 -19.03
EBITDA -33.39M -46.56M -36.8M -18.5M -12.36M -12.7M
Depreciation & Amortization 3.68M 1.81M 685K 209K 73K 44K